Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Naoyo Motoyama"'
Autor:
Katsuya Morita, Seiji Shiraishi, Naoyo Motoyama, Tomoya Kitayama, Takashi Kanematsu, Yasuhito Uezono, Toshihiro Dohi
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91746 (2014)
Bone cancer pain is the most severe among cancer pain and is often resistant to current analgesics. Thus, the development of novel analgesics effective at treating bone cancer pain are desired. Platelet-activating factor (PAF) receptor antagonists we
Externí odkaz:
https://doaj.org/article/fc5716b84f98406c8afa26062897669e
Publikováno v:
Neurochemistry International. 101:120-131
We previously demonstrated, using a DNA microarray analysis, the down-regulated expression of the slc30a1 gene (zinc transporter 1, ZnT1) in a neuropathic pain model induced by partial sciatic nerve ligation (PSNL). Zinc is an essential trace mineral
Autor:
Tomoya Kitayama, Naoyo Motoyama, Fusanori Nishimura, Katsuya Morita, Yasuhito Uezono, Seiji Shiraishi, Takashi Kanematsu, Toshihiro Dohi
Publikováno v:
European Journal of Pain. 17:1156-1167
Background Platelet-activating factor (PAF) has been implicated in the pathology of neuropathic pain. Previous studies reported that PAF receptor (PAF-R) antagonists have varied anti-allodynia effects by route of administration and nerve injury model
Autor:
Katsuya Morita, Yuno Kawai, Midori Hashimoto, Naoyo Motoyama, Kazuna Kato, Mari Sanai, Tomoya Kitayama, Toshihiro Dohi, Akiko Tsuchii
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO2-2
Autor:
Yui Jodo, Naoyo Motoyama, Katsuya Morita, Mayu Shigaki, Toshihiro Dohi, Sayaka Asano, Mari Sanai
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO2-2
Publikováno v:
Pharmacology & Therapeutics. 123:54-79
Injury to peripheral or spinal nerves following either trauma or disease has several consequences including the development of neuropathic pain. This syndrome is often refractory against conventional analgesics; and thus, novel medicaments are desire
Autor:
Naoyo Motoyama, Tomoya Kitayama, Katsuya Morita, Toshihiro Dohi, Koki Kifune, Norimitsu Morioka
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 326:633-645
Neuropathic pain is refractory against conventional analgesics, and thus novel medicaments are desired for the treatment. Glycinergic neurons are localized in specific brain regions, including the spinal cord, where they play an important role in the
Publikováno v:
Folia Pharmacologica Japonica. 130:458-463
神経因性疼痛は難治性で従来の鎮痛薬が奏効せず,新しい薬が期待されている.グリシン作動性ニューロンは脊髄を含む脳の特定部位に局在し,痛みシグナルの伝達を調節する重要な役
Publikováno v:
Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 146(2)
Autor:
Seiji Shiraishi, Yasuhito Uezono, Naoyo Motoyama, Toshihiro Dohi, Katsuya Morita, Tomoya Kitayama, Takashi Kanematsu
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 3, p e91746 (2014)
PLoS ONE, Vol 9, Iss 3, p e91746 (2014)
Bone cancer pain is the most severe among cancer pain and is often resistant to current analgesics. Thus, the development of novel analgesics effective at treating bone cancer pain are desired. Platelet-activating factor (PAF) receptor antagonists we